From: Opioid-free versus opioid-based anesthesia in pancreatic surgery
Characteristic | Total (n = 77) | OBA (n = 42) | OFA (n = 35) | P |
---|---|---|---|---|
Demographic Features | ||||
Age (years) | 67 [27–85] | 68 [27–85] | 66 [39–81] | 0.66 |
Female | 30 (39%) | 20 (47.6%) | 10 (28.6%) | 0.23 |
BMI (kg/m2) | 27 [18–39] | 27 [18–39] | 27 [20–36] | 0.44 |
Perioperative Factors | ||||
Procedures | ||||
Pancreaticoduodenectomy | 54 (70.1%) | 31 (73.8%) | 23 (65.7%) | 0.96 |
Distal Pancreatectomy | 21 (27.3%) | 10 (23.8%) | 11 (31.4%) | |
Other | 2 (2.6%) | 1 (2.4%) | 1 (2.9%) | |
Operative time (minutes) | 360 [103–660] | 359 [166–660] | 364 [103–544] | 0.8 |
Atropine | 7 (9.1%) | 5 (11,9%) | 2 (5,7%) | 0.14 |
Norepinephrine (\(\upmu\) g/kg/min) | 0.043 [0–0.2] | 0.049 [0–0.2] | 0.037 [0–0.11] | 0.73 |
Blood loss (ml) | 625 [50–3400] | 700 [100–2600] | 490 [50–3400] | 0.59 |
Time to extubation (minutes) | 7.0 [1.5–47] | 7.0 [1.5–42] | 7.5 [2–47] | 0.88 |
Time to PACU discharge (Hours) | 18.2 [7.1–21.7] | 19.3 [7.1–20.9] | 18.3 [7.9–21.7] | 0.94 |
Length of stay (days) | 12 [6–46] | 14 [7–46] | 10 [6–16] | < 0.001*** |
Index Complications | ||||
Clavien-Dindo | ||||
None | 7 (9.0%) | 3 (7%) | 4 (11.4%) | 0.86 |
Grade I | 31 (39.7%) | 13 (30.2%) | 18 (51.4%) | |
Grade II | 21 (26.9%) | 15 (34.9%) | 6 (17.1%) | |
Grade III | 11 (14.1%) | 7 (16.3%) | 4 (11.4%) | |
Grade IV | 5 (6.4%) | 3 (7.0%) | 2 (5.7%) | |
Grade V | 3 (3.9%) | 2 (4.7%) | 1 (2.9%) | |
CCI | 20.9 [0–100] | 20.9 [0–100] | 0 [0–100] | 0.03* |
POPF | ||||
None | 63 (81.8%) | 33 (78.5%) | 30 (85.7%) | 0.76 |
Grade A | 4 (5.2%) | 2 (4.8%) | 2 (5.7%) | |
Grade B | 9 (11.7%) | 7 (16.7%) | 2 (5.7%) | |
Grade C | 1 (1.3%) | 0 (0%) | 1 (2.9%) | |
DGE | ||||
None | 66 (85.7%) | 32 (76.2%) | 34 (97.1%) | 0.31 |
Grade A | 2 (2.6%) | 2 (4.8%) | 0 (0%) | |
Grade B | 7 (9.1%) | 6 (14.2%) | 1 (2.9%) | |
Grade C | 2 (2.6%) | 2 (4.8%) | 0 (0%) | |
Readmission | 9 (11.7%) | 8 (19%) | 1 (2.9%) | 0.09 |
30-Day mortality | 10 (13%) | 7 (16.7%) | 3 (8.6%) | 0.53 |